Loading clinical trials...
Loading clinical trials...
Hereditary haemorrhagic telangiectasia (HHT) is a rare autosomal dominant genetic disease associated with mutations in genes encoding proteins of the transforming growth factor β (TGF-β) family, i.e. ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NCT07445347 · Hereditary Hemorrhagic Telangiectasia (HHT), Pulmonary Hypertension, and more
NCT04404881 · Hereditary Hemorrhagic Telangiectasia
NCT04874558 · Hereditary Hemorrhagic Telangiectasia
NCT04646356 · Hereditary Hemorrhagic Telangiectasia, Epistaxis Nosebleed
NCT03397004 · Hereditary Hemorrhagic Telangiectasia (HHT)
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions